0R1B Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biogen Inc

Watchlist Manager

Watchlist

Price: 214.54 USD 2.31%

Market Cap: $31.3B

B	Biogen Inc LSE:0R1B	US
	Northrop Grumman Corp NYSE:NOC	US
S	SK Growth Opportunities Corp NASDAQ:SKGR	US
A	ANTA Sports Products Ltd XBER:AS7	CN
S	Swatch Group AG XMUN:UHRN	CH
D	Dropbox Inc SWB:1Q5	US
A	Active Biotech AB publ F:BTPC	SE
W	WEX Inc F:WL9	US
	LSI Industries Inc NASDAQ:LYTS	US
D	DR Horton Inc SWB:HO2	US
	Swatch Group AG F:UHRA	CH
	Siam Makro PCL OTC:SMKUY	TH

Profitability Summary

Biogen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

76%

Declining Gross Margin

77% > 75%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

26%

Declining Operating Margin

30% > 26%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

27% > 14%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

18%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.